{"id":"https://openalex.org/W2162342078","doi":"https://doi.org/10.1109/icmens.2004.1508923","title":"Preliminary Results of Nanopharmaceuticals Used in the Radioimmunotherapy of Ovarian Cancer","display_name":"Preliminary Results of Nanopharmaceuticals Used in the Radioimmunotherapy of Ovarian Cancer","publication_year":2006,"publication_date":"2006-10-11","ids":{"openalex":"https://openalex.org/W2162342078","doi":"https://doi.org/10.1109/icmens.2004.1508923","mag":"2162342078","pmid":"https://pubmed.ncbi.nlm.nih.gov/15850546"},"language":"en","primary_location":{"id":"doi:10.1109/icmens.2004.1508923","is_oa":false,"landing_page_url":"https://doi.org/10.1109/icmens.2004.1508923","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2004 International Conference on MEMS, NANO and Smart Systems (ICMENS'04)","raw_type":"proceedings-article"},"type":"conference-paper","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108413668","display_name":"S.A. McQuarrie","orcid":null},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"S.A. McQuarrie","raw_affiliation_strings":["Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015171119","display_name":"Gerald G. Miller","orcid":null},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"G.G. Miller","raw_affiliation_strings":["Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109831799","display_name":"M.R. Suresh","orcid":"https://orcid.org/0009-0000-7473-5518"},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"M.R. Suresh","raw_affiliation_strings":["Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011868749","display_name":"John R. Mercer","orcid":"https://orcid.org/0000-0002-3204-7511"},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"J.R. Mercer","raw_affiliation_strings":["Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I154425047"],"apc_list":null,"apc_paid":null,"fwci":8.97,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.98694943,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":98},"biblio":{"volume":"56","issue":"4","first_page":"92","last_page":"94"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.8539999723434448,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.8539999723434448,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","score":0.025699999183416367,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.01360000018030405,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"Radioimmunotherapy","score":0.7616338729858398},{"id":"https://openalex.org/keywords/monoclonal-antibody","display_name":"Monoclonal antibody","score":0.6955969929695129},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"Ovarian cancer","score":0.68942791223526},{"id":"https://openalex.org/keywords/cancer-research","display_name":"Cancer research","score":0.6037694215774536},{"id":"https://openalex.org/keywords/biotinylation","display_name":"Biotinylation","score":0.5781551599502563},{"id":"https://openalex.org/keywords/in-vivo","display_name":"In vivo","score":0.5289998650550842},{"id":"https://openalex.org/keywords/epitope","display_name":"Epitope","score":0.5059983134269714},{"id":"https://openalex.org/keywords/cytotoxic-t-cell","display_name":"Cytotoxic T cell","score":0.47542527318000793},{"id":"https://openalex.org/keywords/pretargeting","display_name":"Pretargeting","score":0.4749605655670166},{"id":"https://openalex.org/keywords/radionuclide-therapy","display_name":"Radionuclide therapy","score":0.467191219329834},{"id":"https://openalex.org/keywords/adjuvant","display_name":"Adjuvant","score":0.4361025094985962},{"id":"https://openalex.org/keywords/medicine","display_name":"Medicine","score":0.42104125022888184},{"id":"https://openalex.org/keywords/pharmacology","display_name":"Pharmacology","score":0.40565013885498047},{"id":"https://openalex.org/keywords/chemistry","display_name":"Chemistry","score":0.37641313672065735},{"id":"https://openalex.org/keywords/cancer","display_name":"Cancer","score":0.36011427640914917},{"id":"https://openalex.org/keywords/antibody","display_name":"Antibody","score":0.339865505695343},{"id":"https://openalex.org/keywords/biology","display_name":"Biology","score":0.28149086236953735},{"id":"https://openalex.org/keywords/immunology","display_name":"Immunology","score":0.24932122230529785},{"id":"https://openalex.org/keywords/internal-medicine","display_name":"Internal medicine","score":0.2131325602531433},{"id":"https://openalex.org/keywords/in-vitro","display_name":"In vitro","score":0.16971847414970398},{"id":"https://openalex.org/keywords/biochemistry","display_name":"Biochemistry","score":0.12677142024040222}],"concepts":[{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.7616338729858398},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6955969929695129},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.68942791223526},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6037694215774536},{"id":"https://openalex.org/C204628709","wikidata":"https://www.wikidata.org/wiki/Q864854","display_name":"Biotinylation","level":2,"score":0.5781551599502563},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5289998650550842},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.5059983134269714},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.47542527318000793},{"id":"https://openalex.org/C2777836882","wikidata":"https://www.wikidata.org/wiki/Q22907915","display_name":"Pretargeting","level":5,"score":0.4749605655670166},{"id":"https://openalex.org/C2993559085","wikidata":"https://www.wikidata.org/wiki/Q2126444","display_name":"Radionuclide therapy","level":2,"score":0.467191219329834},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.4361025094985962},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42104125022888184},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40565013885498047},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.37641313672065735},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36011427640914917},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.339865505695343},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28149086236953735},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24932122230529785},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2131325602531433},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.16971847414970398},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12677142024040222},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D016499","descriptor_name":"Radioimmunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D016499","descriptor_name":"Radioimmunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D016499","descriptor_name":"Radioimmunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1109/icmens.2004.1508923","is_oa":false,"landing_page_url":"https://doi.org/10.1109/icmens.2004.1508923","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2004 International Conference on MEMS, NANO and Smart Systems (ICMENS'04)","raw_type":"proceedings-article"},{"id":"pmid:15850546","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15850546","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8500000238418579,"id":"https://metadata.un.org/sdg/3"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1971714655","https://openalex.org/W1972645118","https://openalex.org/W1983528694","https://openalex.org/W2012338478","https://openalex.org/W2033968575","https://openalex.org/W2047096261","https://openalex.org/W2049940095","https://openalex.org/W2057107672","https://openalex.org/W2075220689","https://openalex.org/W2083037331","https://openalex.org/W2090194845","https://openalex.org/W2097468978","https://openalex.org/W2160414836","https://openalex.org/W2162836871","https://openalex.org/W2213133654","https://openalex.org/W2328421677","https://openalex.org/W2401421433","https://openalex.org/W2418394147"],"related_works":["https://openalex.org/W2188170947","https://openalex.org/W1979401181","https://openalex.org/W4256417123","https://openalex.org/W2184100701","https://openalex.org/W2930828635","https://openalex.org/W4251714812","https://openalex.org/W48525853","https://openalex.org/W2066823601","https://openalex.org/W4211120843","https://openalex.org/W1992760392"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1],"treatment":[2,44,180],"of":[3,26,63,77,98,174,208],"late":[4],"stage":[5],"ovarian":[6,47,164],"cancer":[7,165],"presents":[8],"an":[9,50,108,203],"unmet":[10],"clinical":[11],"need":[12],"for":[13,45,107,123,177,185],"women":[14],"around":[15],"the":[16,24,64,75,81,99,105,133,159,178,186],"world.":[17],"A":[18,113,169],"multistep":[19],"radioimmunotherapeutic":[20],"(RIT)":[21],"approach,":[22],"exploiting":[23],"combination":[25],"a":[27,41],"bispecific":[28],"monoclonal":[29,87],"antibody":[30,88],"(BsMAb)":[31],"with":[32,68,85,115,125,129,152,158],"90Y":[33,136],"labelled":[34],"biotinylated":[35],"long-circulating":[36],"liposomes":[37,127],"was":[38,58,121,145,189],"tested":[39],"as":[40],"potential":[42],"adjuvant":[43],"epithelial":[46],"carcinomatosis":[48],"in":[49,71,141,206,213],"attempt":[51],"to":[52,60,73,80,131,137,147],"meet":[53],"this":[54,149,199],"need.":[55],"This":[56],"approach":[57],"used":[59,146],"overcome":[61],"some":[62],"major":[65],"obstacles":[66],"associated":[67],"conventional":[69,86],"strategies,":[70],"particular,":[72],"increase":[74],"amount":[76],"radioactivity":[78],"delivered":[79],"tumor":[82,138,171,194,209],"site":[83],"compared":[84],"(MAb)":[89],"radionuclide":[90,135],"delivery.":[91],"We":[92],"hypothesize":[93],"that":[94],"sequential":[95],"intraperitoneal":[96],"administration":[97],"targeting":[100],"and":[101,118,210],"therapeutic":[102,110],"moieties":[103],"provides":[104],"basis":[106],"enhanced":[109],"ratio.":[111],"METHODS:":[112],"BsMAb,":[114],"anti-CA":[116],"125":[117],"anti-biotin":[119],"epitopes":[120],"engineered":[122],"use":[124],"PEGylated":[126],"coated":[128],"biotin":[130],"deliver":[132],"cytotoxic":[134],"sites.":[139],"An":[140,192],"vivo":[142],"therapy":[143],"trial":[144],"test":[148],"RIT":[150],"protocol":[151],"Balb/c":[153],"nude":[154],"mice":[155],"(n=29)":[156],"xenografted":[157],"NIH:OVCAR-3":[160],"(CA":[161],"125+)":[162],"human":[163],"cell":[166],"line.":[167],"RESULTS:":[168],"median":[170],"growth":[172,195],"delay":[173,205],"91":[175],"days":[176,184],"combined":[179],"group":[181,188],"versus":[182],"77.7":[183],"control":[187,216],"observed.":[190],"CONCLUSION:":[191],"ongoing":[193],"delay/control":[196],"study":[197],"using":[198],"model":[200],"has":[201],"indicated":[202],"appreciable":[204],"progress":[207],"ascites":[211],"development":[212],"treated":[214],"vs.":[215],"populations.":[217]},"counts_by_year":[{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-07-29T14:22:42.915294","created_date":"2025-10-10T00:00:00"}